CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- NT 10-Q Other NT 10-Q
- 8-K Event Results of operations
- 8-K Event Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Shareholder vote results · Regulation FD disclosure
- 4 Grant or award Chief Medical Officer acquired 80,645 shares (grant or award)
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 4,167 shares (grant or award)
- 4 Grant or award Director acquired 4,167 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Grant or award Director acquired 8,333 shares (grant or award)
- 4 Grant or award Director acquired 4,167 shares (grant or award)
- 4 Grant or award Director acquired 4,167 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Exit or restructuring costs
- 8-K Event Executive or director change
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
Page 14 of 65 · 1,296 filings